Report Australia and Oceania - Medicaments Containing Penicillins or Derivatives Thereof - Market Analysis, Forecast, Size, Trends and Insights for 499$
Report Update Nov 1, 2024

Australia and Oceania - Medicaments Containing Penicillins or Derivatives Thereof - Market Analysis, Forecast, Size, Trends and Insights

Single report
Sent by email within 24h (Mon-Fri)
Subscription
Online access and download
from $350/month

Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.

View Pricing

Australia and Oceania: Medicaments Containing Penicillin Market 2024

Medicaments Containing Penicillin Market Size in Australia and Oceania

In 2021, the medicaments containing penicillin market in Australia and Oceania was finally on the rise to reach $X for the first time since 2018, thus ending a two-year declining trend. Overall, consumption showed a resilient increase. As a result, consumption reached the peak level of $X. From 2019 to 2021, the growth of the market remained at a lower figure.

Medicaments Containing Penicillin Production in Australia and Oceania

In value terms, medicaments containing penicillin production reached $X in 2021 estimated in export price. Over the period under review, production saw a resilient expansion. The pace of growth appeared the most rapid in 2018 with an increase of 371%. As a result, production reached the peak level of $X. From 2019 to 2021, production growth failed to regain momentum.

Medicaments Containing Penicillin Exports

Exports in Australia and Oceania

In 2021, exports of medicaments containing penicillins or derivatives thereof in Australia and Oceania skyrocketed to X tons, rising by 270% on 2020. Overall, exports, however, showed a abrupt descent. The volume of export peaked at X tons in 2014; however, from 2015 to 2021, the exports remained at a lower figure.

In value terms, medicaments containing penicillin exports declined to $X in 2021. Over the period under review, exports, however, showed a sharp descent. The pace of growth appeared the most rapid in 2018 with an increase of 112%. Over the period under review, the exports reached the peak figure at $X in 2013; however, from 2014 to 2021, the exports stood at a somewhat lower figure.

Exports by Country

Australia dominates exports structure, reaching X tons, which was approx. 91% of total exports in 2021. It was distantly followed by New Zealand (X tons), constituting a 7.4% share of total exports.

Australia was also the fastest-growing in terms of the medicaments containing penicillins or derivatives thereof exports, with a CAGR of -8.4% from 2012 to 2021. New Zealand (-18.3%) illustrated a downward trend over the same period. Australia (+11 p.p.) significantly strengthened its position in terms of the total exports, while New Zealand saw its share reduced by -10.7% from 2012 to 2021, respectively.

In value terms, Australia ($X) remains the largest medicaments containing penicillin supplier in Australia and Oceania, comprising 83% of total exports. The second position in the ranking was taken by New Zealand ($X), with a 16% share of total exports.

In Australia, medicaments containing penicillin exports plunged by an average annual rate of -26.5% over the period from 2012-2021.

Export Prices by Country

In 2021, the export price in Australia and Oceania amounted to $X per ton, reducing by -73.9% against the previous year. Over the period under review, the export price faced a abrupt descent. The pace of growth was the most pronounced in 2018 when the export price increased by 87%. Over the period under review, the export prices reached the maximum at $X per ton in 2012; however, from 2013 to 2021, the export prices remained at a lower figure.

Prices varied noticeably by country of origin: amid the top suppliers, the country with the highest price was New Zealand ($X per ton), while Australia totaled $X per ton.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by New Zealand (+2.2%).

Medicaments Containing Penicillin Imports

Imports in Australia and Oceania

In 2021, after three years of decline, there was significant growth in overseas purchases of medicaments containing penicillins or derivatives thereof, when their volume increased by 51% to X tons. In general, imports, however, recorded a significant decrease. Over the period under review, imports reached the maximum at X tons in 2012; however, from 2013 to 2021, imports remained at a lower figure.

In value terms, medicaments containing penicillin imports surged to $X in 2021. Over the period under review, imports, however, saw a abrupt decrease. The pace of growth appeared the most rapid in 2017 with an increase of 29%. The level of import peaked at $X in 2012; however, from 2013 to 2021, imports failed to regain momentum.

Imports by Country

Australia represented the major importer of medicaments containing penicillins or derivatives thereof in Australia and Oceania, with the volume of imports recording X tons, which was approx. 40% of total imports in 2021. Marshall Islands (X tons) held a 19% share (based on physical terms) of total imports, which put it in second place, followed by Palau (13%), Fiji (7.5%) and Samoa (7%). The following importers - Micronesia (X kg) and Papua New Guinea (X kg) - each amounted to a 6% share of total imports.

Imports into Australia decreased at an average annual rate of -6.5% from 2012 to 2021. At the same time, Palau (+32.6%) and Marshall Islands (+13.8%) displayed positive paces of growth. Moreover, Palau emerged as the fastest-growing importer imported in Australia and Oceania, with a CAGR of +32.6% from 2012-2021. By contrast, Samoa (-4.7%), Papua New Guinea (-11.1%), Fiji (-29.6%) and Micronesia (-34.1%) illustrated a downward trend over the same period. While the share of Australia (+31 p.p.), Marshall Islands (+18 p.p.), Palau (+13 p.p.), Samoa (+5.5 p.p.) and Papua New Guinea (+1.7 p.p.) increased significantly in terms of the total imports from 2012-2021, the share of Micronesia (-15.5 p.p.) and Fiji (-15.9 p.p.) displayed negative dynamics.

In value terms, Australia ($X) constitutes the largest market for imported medicaments containing penicillins or derivatives thereof in Australia and Oceania, comprising 46% of total imports. The second position in the ranking was taken by Marshall Islands ($X), with a 16% share of total imports. It was followed by Fiji, with a 12% share.

From 2012 to 2021, the average annual growth rate of value in Australia amounted to -4.7%. In the other countries, the average annual rates were as follows: Marshall Islands (+23.0% per year) and Fiji (-19.0% per year).

Import Prices by Country

The import price in Australia and Oceania stood at $X per ton in 2021, falling by -16.4% against the previous year. Over the period under review, the import price, however, recorded a prominent increase. The pace of growth appeared the most rapid in 2014 when the import price increased by 46%. The level of import peaked at $X per ton in 2020, and then declined significantly in the following year.

Prices varied noticeably by country of destination: amid the top importers, the country with the highest price was Fiji ($X per ton), while Micronesia ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Fiji (+15.2%), while the other leaders experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :

Australia constituted the country with the largest volume of medicaments containing penicillin consumption, accounting for 84% of total volume. Moreover, medicaments containing penicillin consumption in Australia exceeded the figures recorded by the second-largest consumer, New Zealand, fivefold.
Australia remains the largest medicaments containing penicillin producing country in Australia and Oceania, comprising approx. 84% of total volume. Moreover, medicaments containing penicillin production in Australia exceeded the figures recorded by the second-largest producer, New Zealand, fivefold.
In value terms, Australia remains the largest medicaments containing penicillin supplier in Australia and Oceania, comprising 97% of total exports. The second position in the ranking was occupied by New Zealand, with a 2.4% share of total exports.
In value terms, the largest medicaments containing penicillin importing markets in Australia and Oceania were Australia, Fiji and Papua New Guinea, together accounting for 90% of total imports.
The medicaments containing penicillin export price in Australia and Oceania stood at $315,532 per ton in 2020, jumping by 71% against the previous year.
The medicaments containing penicillin import price in Australia and Oceania stood at $96,205 per ton in 2020, with an increase of 14% against the previous year.

This report provides an in-depth analysis of the medicaments containing penicillin market in Australia and Oceania. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.

Product coverage:

  • Prodcom 21201130 - Medicaments containing penicillins or derivatives thereof, with a penicillanic acid structure, or streptomycins or their derivatives, for therapeutic or prophylactic uses, n.p.r.s.

Country coverage:

  • Australia
  • Cook Islands
  • Fiji
  • French Polynesia
  • Kiribati
  • Marshall Islands
  • Micronesia
  • New Caledonia
  • New Zealand
  • Northern Mariana Islands
  • Palau
  • Papua New Guinea
  • Samoa
  • Solomon Islands
  • Tokelau
  • Tonga
  • Tuvalu
  • Vanuatu
  • Wallis and Futuna Islands
  • American Samoa
  • Nauru
  • Niue
  • Guam

Data coverage:

  • Market volume and value
  • Per Capita consumption
  • Forecast of the market dynamics in the medium term
  • Production in Australia and Oceania, split by region and country
  • Trade (exports and imports) in Australia and Oceania
  • Export and import prices
  • Market trends, drivers and restraints
  • Key market players and their profiles

Reasons to buy this report:

  • Take advantage of the latest data
  • Find deeper insights into current market developments
  • Discover vital success factors affecting the market

This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:

  1. How to diversify your business and benefit from new market opportunities
  2. How to load your idle production capacity
  3. How to boost your sales on overseas markets
  4. How to increase your profit margins
  5. How to make your supply chain more sustainable
  6. How to reduce your production and supply chain costs
  7. How to outsource production to other countries
  8. How to prepare your business for global expansion

While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.

  1. 1. INTRODUCTION

    Making Data-Driven Decisions to Grow Your Business

    1. REPORT DESCRIPTION
    2. RESEARCH METHODOLOGY AND AI PLATFORM
    3. DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
    4. GLOSSARY AND SPECIFIC TERMS
  2. 2. EXECUTIVE SUMMARY

    A Quick Overview of Market Performance

    1. KEY FINDINGS
    2. MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
  3. 3. MARKET OVERVIEW

    Understanding the Current State of The Market and Its Prospects

    1. MARKET SIZE
    2. CONSUMPTION BY COUNTRY
    3. MARKET FORECAST TO 2030
  4. 4. MOST PROMISING PRODUCT

    Finding New Products to Diversify Your Business

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
    2. BEST-SELLING PRODUCTS
    3. MOST CONSUMED PRODUCT
    4. MOST TRADED PRODUCT
    5. MOST PROFITABLE PRODUCT FOR EXPORT
  5. 5. MOST PROMISING SUPPLYING COUNTRIES

    Choosing the Best Countries to Establish Your Sustainable Supply Chain

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP COUNTRIES TO SOURCE YOUR PRODUCT
    2. TOP PRODUCING COUNTRIES
    3. TOP EXPORTING COUNTRIES
    4. LOW-COST EXPORTING COUNTRIES
  6. 6. MOST PROMISING OVERSEAS MARKETS

    Choosing the Best Countries to Boost Your Exports

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
    2. TOP CONSUMING MARKETS
    3. UNSATURATED MARKETS
    4. TOP IMPORTING MARKETS
    5. MOST PROFITABLE MARKETS
  7. 7. PRODUCTION

    The Latest Trends and Insights into The Industry

    1. PRODUCTION VOLUME AND VALUE
    2. PRODUCTION BY COUNTRY
  8. 8. IMPORTS

    The Largest Importers on The Market and How They Succeed

    1. IMPORTS FROM 2012–2023
    2. IMPORTS BY COUNTRY
    3. IMPORT PRICES BY COUNTRY
  9. 9. EXPORTS

    The Largest Exporters on The Market and How They Succeed

    1. EXPORTS FROM 2012–2023
    2. EXPORTS BY COUNTRY
    3. EXPORT PRICES BY COUNTRY
  10. 10. PROFILES OF MAJOR PRODUCERS

    The Largest Producers on The Market and Their Profiles

    This Chapter is Available Only for the Professional Edition PRO
  11. 11. COUNTRY PROFILES

    The Largest Markets And Their Profiles

    This Chapter is Available Only for the Professional Edition PRO
    • Australia
    • Cook Islands
    • Fiji
    • French Polynesia
    • Kiribati
    • Marshall Islands
    • Micronesia
    • New Caledonia
    • New Zealand
    • Northern Mariana Islands
    • Palau
    • Papua New Guinea
    • Samoa
    • Solomon Islands
    • Tokelau
    • Tonga
    • Tuvalu
    • Vanuatu
    • Wallis and Futuna Islands
    • American Samoa
    • Nauru
    • Niue
    • Guam
  12. LIST OF TABLES

    1. Key Findings In 2023
    2. Market Volume, In Physical Terms, 2012–2023
    3. Market Value, 2012–2023
    4. Per Capita Consumption, By Country, 2018–2023
    5. Production, In Physical Terms, By Country, 2012–2023
    6. Imports, In Physical Terms, By Country, 2012–2023
    7. Imports, In Value Terms, By Country, 2012–2023
    8. Import Prices, By Country Of Destination, 2012–2023
    9. Exports, In Physical Terms, By Country, 2012–2023
    10. Exports, In Value Terms, By Country, 2012–2023
    11. Export Prices, By Country Of Origin, 2012–2023
  13. LIST OF FIGURES

    1. Market Volume, In Physical Terms, 2012–2023
    2. Market Value, 2012–2023
    3. Consumption, By Country, 2023
    4. Market Volume Forecast to 2030
    5. Market Value Forecast to 2030
    6. Products: Market Size And Growth, By Type
    7. Products: Average Per Capita Consumption, By Type
    8. Products: Exports And Growth, By Type
    9. Products: Export Prices And Growth, By Type
    10. Production Volume And Growth
    11. Exports And Growth
    12. Export Prices And Growth
    13. Market Size And Growth
    14. Per Capita Consumption
    15. Imports And Growth
    16. Import Prices
    17. Production, In Physical Terms, 2012–2023
    18. Production, In Value Terms, 2012–2023
    19. Production, By Country, 2023
    20. Production, In Physical Terms, By Country, 2012–2023
    21. Imports, In Physical Terms, 2012–2023
    22. Imports, In Value Terms, 2012–2023
    23. Imports, In Physical Terms, By Country, 2023
    24. Imports, In Physical Terms, By Country, 2012–2023
    25. Imports, In Value Terms, By Country, 2012–2023
    26. Import Prices, By Country, 2012–2023
    27. Exports, In Physical Terms, 2012–2023
    28. Exports, In Value Terms, 2012–2023
    29. Exports, In Physical Terms, By Country, 2023
    30. Exports, In Physical Terms, By Country, 2012–2023
    31. Exports, In Value Terms, By Country, 2012–2023
    32. Export Prices, 2012–2023

Recommended reports

Free Data: Medicaments Containing Penicillins Or Derivatives Thereof - Australia and Oceania